Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

European reg for children’s meds

This article was originally published in The Tan Sheet

Executive Summary

The European Commission reached an agreement on an updated regulatory approach for pediatric medicines, according to the UK's Medicines & Healthcare products Regulatory Agency (MHRA) June 1. "The overall policy objective is to improve the health of the children of Europe by increasing the research, development and authorization of medicines for use in children," the proposal for the regulation states. Specific objectives of the measure include increasing development for children's medicines, improving the quality of research for children's medicinal products and ensuring that all medicines used for children are appropriate for pediatric use. MHRA expects that the proposed regulation will be passed into law by the end of 2006...
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS099432

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel